Free tool
Oncology stocks
We cover 13 companies grouped under the Oncology theme. The median market value in the group is $244.61M. Across the group, the median move over the past trading day is 0.00%. Price change over the past year runs from −71.1% to +348.4% across the middle 80 percent of the group, with a median of +2.9%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
13 of 319 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| RCUS | Arcus Biosciences, Inc. | $3.92B | Mid cap | +191.29% | Oct 27, 2026 |
| NRIX | Nurix Therapeutics, Inc. | $2.77B | Mid cap | +179.69% | Oct 8, 2026 |
| NBTX | Nanobiotix S.A. | $2.26B | Mid cap | +394.99% | Sep 29, 2026 |
| NANO.PA | Nanobiotix S.A. | $2.25B | Mid cap | +387.64% | Sep 29, 2026 |
| PRTC.L | PureTech Health plc | $420.70M | Small cap | +2.43% | Sep 3, 2026 |
| IPHA | Innate Pharma S.A. | $253.56M | Small cap | +2.86% | Sep 17, 2026 |
| IPH.PA | Innate Pharma S.A. | $244.61M | Small cap | +3.36% | Sep 17, 2026 |
| IDD.DE | Innate Pharma S.A. | $231.60M | Small cap | −2.52% | Sep 17, 2026 |
| ANIX | Anixa Biosciences, Inc. | $122.65M | Small cap | +22.20% | Sep 9, 2026 |
| OSE.PA | OSE Immunotherapeutics SA | $90.43M | Micro cap | −46.85% | Sep 28, 2026 |
| IMMP | Immutep Limited | $56.00M | Micro cap | −77.11% | Sep 2, 2026 |
| BLRX | BioLineRx Ltd. | $11.79M | Micro cap | −26.63% | Aug 31, 2026 |
| LNAI | Lunai Bioworks Inc. | $9.97M | Micro cap | −89.34% | Sep 28, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.